Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial

Many patients with severe asthma require chronic corticosteroid treatment to maintain asthma control. Are the reduction in oral corticosteroid (OCS) use and the clinical efficacy observed with dupilumab treatment maintained long-term in patients with severe OCS-dependent asthma? The LIBERTY ASTHMA T...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chest 2022-07, Vol.162 (1), p.46-55
Hauptverfasser:	Sher, Lawrence D, Wechsler, Michael E, Rabe, Klaus F, Maspero, Jorge F, Daizadeh, Nadia, Mao, Xuezhou, Ortiz, Benjamin, Mannent, Leda P, Laws, Elizabeth, Ruddy, Marcella, Pandit-Abid, Nami, Jacob-Nara, Juby A, Gall, Rebecca, Rowe, Paul J, Deniz, Yamo, Lederer, David J, Hardin, Megan
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!